BASF Venture Capital GmbH is investing in Prismlab, a provider of 3D printing processes and 3D printers, headquartered in Shanghai, China. Financial details were not disclosed. Prismlab has developed a patented printing process based on stereolithography (SLA) that is characterised by a very high printing speed, high level of precision and lower printing costs. SLA allows comparatively large and stable components, such as medical braces and anatomical models, to be produced using light-curing resins.
Menü
Klicken Sie auf den unteren Button, um die Sprachumschalter über GoogleTranslate zu laden.
PGRpdiBjbGFzcz0iZ3RyYW5zbGF0ZV93cmFwcGVyIiBpZD0iZ3Qtd3JhcHBlci00ODMxODUyNSI+PC9kaXY+